Madison Square Garden Sports Corp. MSGS
Composite 41/100; the shares have moved about 25% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 14/100 — a strong mark against it.
Momentum ranks 63/100 — a moderate point in its favour. Growth ranks 56/100 — a slight point in its favour.
Valuation ranks 14/100 — a strong mark against it. Quality ranks 33/100 — a moderate mark against it. Balance-sheet strength ranks 47/100 — a slight mark against it.
What the company does Madison Square Garden Sports Corp. (MSGS) owns and operates major New York sports franchises, including the NBA’s New York Knicks and the NHL’s New York Rangers, alongside development league teams and a training center.
Key financials MSGS shows weak profitability with gross margins at 29.4% but operating and net margins at 0.7% and -2.1%, respectively. ROE is -12.3%, ROA -1.0%, and ROCE -2.4%. Revenue growth is modest at 1.9%, though EPS growth is high at 644.9%.
Stock health The stock exhibits strong momentum with 12-month returns of 101.44% and an RSI(14) of 64.80, indicating bullish sentiment. However, liquidity is concerning with a current ratio of 0.46 and interest coverage at -0.98.
Price vs fair value MSGS trades at a PREMIUM of 87.30% versus our fair-value estimate of 51.32 and at a discount of 8.92% versus the analyst 12-month target of 441.17. - Weak profitability metrics (ROE -12.3%, ROA -1.0%) (Key Financials) - High forward P/E of 72.46 and EV/EBITDA of 501.30 (Valuation) - Strong 12-month momentum of 101.44% (Momentum) - Poor quality score of 15.8 (Sideravia Score)
Looking forward Forward valuation remains stretched at a P/E of 72.46, but momentum and franchise assets may justify premium pricing. Investors should monitor profitability improvements and liquidity management.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.